Zdrowie i gospodarka · 01/11/2019
FDA Announces Draft Guidance for Chronic Hepatitis D Virus Infection Treatment
The FDA is releasing a draft guidance to help pharmaceutical companies develop effective treatments for chronic hepatitis D virus infection, aiming to provide consistent advice on drug development strategies.